Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
21 hedge funds and large institutions have $343K invested in Celgene Corporation Contingent Value Rights in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
5% more funds holding
Funds holding: 20 → 21 (+1)
69% less capital invested
Capital invested by funds: $1.1M → $343K (-$754K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$101K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$19.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$36K |
| 2 |
CC
Cannell & Co
New York
|
-$28.4K |
| 3 |
DC
Davenport & Co
Richmond,
Virginia
|
-$4.56K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.78K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$538 |
CELGZ Hedge Fund Activity: Q4 2018 in Review
21 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q4 2018, worth a combined $343K — down 69% from $1.1M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CELGZ positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 6 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $101K. The largest seller was FCG Advisors, cutting an estimated $36K.
- 21 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q4 2018, up from 20 in Q3 2018.
- Funds reported $343K of Celgene Corporation Contingent Value Rights stock for Q4 2018, down 69% quarter-over-quarter.
- 2 funds opened new Celgene Corporation Contingent Value Rights positions in Q4 2018 and 1 closed out, a net change of +1 holder.
- The largest Celgene Corporation Contingent Value Rights buyer in Q4 2018 was Susquehanna International Group, an estimated $101K added.
- The largest Celgene Corporation Contingent Value Rights seller in Q4 2018 was FCG Advisors, an estimated $36K sold.
Based on aggregated 13F filings for Q4 2018.